X |
Filing Date |
Trade Date |
Ticker |
Company Name | Insider Name | Title |
Trade Type |
Price |
Qty |
Owned |
ΔOwn |
Value |
1d |
1w |
1m |
6m |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
M | 2024-03-01 | AADI | Aadi Bioscience, Inc. | Desai Neil | Exec COB | S - Sale | $2.02 | -42,000 | 2,051,241 | -2% | -$84,641 | |||||
M | 2024-02-15 | ABCP | Ambase Corp | Camac Fund, LP | 10% | S - Sale | $0.24 | -3,178,307 | 4,227,465 | -43% | -$754,539 | |||||
D | 2024-03-05 | ADPT | Adaptive Biotechnologies Corp | Taylor Stacy L | SVP, GC | S - Sale+OE | $3.43 | -13,381 | 166,287 | -7% | -$45,963 | |||||
2024-03-05 | ADPT | Adaptive Biotechnologies Corp | Robins Chad M | CEO, COB | S - Sale | $3.43 | -48,673 | 2,576,701 | -2% | -$167,007 | ||||||
D | 2024-03-05 | ADPT | Adaptive Biotechnologies Corp | Bobulsky Susan | Chief Commercial Officer, MRD | S - Sale+OE | $3.44 | -12,991 | 248,290 | -5% | -$44,629 | |||||
2024-03-05 | ADPT | Adaptive Biotechnologies Corp | Peterson Tycho | CFO | S - Sale | $3.44 | -15,456 | 531,553 | -3% | -$53,169 | ||||||
2024-03-05 | ADPT | Adaptive Biotechnologies Corp | Piskel Kyle | Principal Accounting Officer | S - Sale | $3.43 | -7,727 | 123,318 | -6% | -$26,504 | ||||||
2024-03-05 | ADPT | Adaptive Biotechnologies Corp | Rubinstein Julie | Pres | S - Sale | $3.47 | -39,070 | 472,754 | -8% | -$135,764 | ||||||
D | 2024-03-05 | ADPT | Adaptive Biotechnologies Corp | Lo Francis | Chief People Officer | S - Sale+OE | $3.43 | -14,700 | 256,245 | -5% | -$50,439 | |||||
D | 2024-03-05 | ADPT | Adaptive Biotechnologies Corp | Benzeno Sharon | Chief Commercial Ofc Imm Med | S - Sale+OE | $3.44 | -29,390 | 327,415 | -8% | -$100,994 | |||||
D | 2024-02-15 | AERG | Applied Energetics, Inc. | Adamczyk Bradford Thomas | Exec COB | S - Sale+OE | $1.73 | -10,000 | 2,235,081 | 0% | -$17,300 | |||||
D | 2024-03-15 | AERG | Applied Energetics, Inc. | Adamczyk Bradford Thomas | Exec COB | S - Sale+OE | $2.00 | -10,000 | 2,235,081 | 0% | -$20,000 | |||||
D | 2024-02-21 | AERG | Applied Energetics, Inc. | Quarles Gregory James | Pres, CEO | S - Sale+OE | $1.71 | -10,000 | 0 | -100% | -$17,100 | |||||
2024-02-29 | AKBA | Akebia Therapeutics, Inc. | Burke Steven Keith | SVP, Chief Medical Officer | S - Sale | $1.58 | -7,169 | 695,840 | -1% | -$11,327 | ||||||
2024-02-29 | AKBA | Akebia Therapeutics, Inc. | Butler John P. | CEO, Pres | S - Sale | $1.58 | -46,570 | 2,364,436 | -2% | -$73,581 | ||||||
2024-02-29 | AKBA | Akebia Therapeutics, Inc. | Dahan Michel | SVP, COO | S - Sale | $1.58 | -8,661 | 706,932 | -1% | -$13,684 | ||||||
2024-02-27 | AKBA | Akebia Therapeutics, Inc. | Butler John P. | CEO, Pres | S - Sale | $1.52 | -37,733 | 2,411,006 | -2% | -$57,354 | ||||||
2024-02-27 | AKBA | Akebia Therapeutics, Inc. | Burke Steven Keith | SVP, Chief Medical Officer | S - Sale | $1.52 | -8,367 | 703,009 | -1% | -$12,718 | ||||||
2024-02-27 | AKBA | Akebia Therapeutics, Inc. | Dahan Michel | SVP, COO | S - Sale | $1.52 | -10,744 | 715,593 | -1% | -$16,331 | ||||||
2024-02-27 | AKBA | Akebia Therapeutics, Inc. | Hadas Nicole R. | SVP, GC | S - Sale | $1.52 | -7,411 | 669,233 | -1% | -$11,265 | ||||||
2024-03-13 | AKYA | Akoya Biosciences, Inc. | McKelligon Brian | Pres, CEO | S - Sale | $4.94 | -7,500 | 224,368 | -3% | -$37,035 | ||||||
D | 2024-03-11 | ALDX | Aldeyra Therapeutics, Inc. | Greenberg Bruce | See Remarks | S - Sale+OE | $3.41 | -13,201 | 120,699 | -10% | -$44,968 | |||||
DM | 2024-03-11 | ALDX | Aldeyra Therapeutics, Inc. | Brady Todd C | Pres, CEO | S - Sale+OE | $3.17 | -183,238 | 1,471,298 | -11% | -$580,760 | |||||
DM | 2024-03-11 | ALDX | Aldeyra Therapeutics, Inc. | Machatha Stephen | Chief Development Officer | S - Sale+OE | $3.31 | -29,768 | 243,706 | -11% | -$98,605 | |||||
2024-03-15 | ALHC | Alignment Healthcare, Inc. | Scavo Robert L. | CIO | S - Sale | $4.89 | -4,852 | 441,721 | -1% | -$23,732 | ||||||
2024-03-15 | ALHC | Alignment Healthcare, Inc. | Kardes Hakan | Chief Experience Officer | S - Sale | $4.89 | -4,326 | 453,771 | -1% | -$21,159 | ||||||
2024-03-15 | ALHC | Alignment Healthcare, Inc. | Freeman Robert Thomas | CFO | S - Sale | $4.89 | -11,858 | 1,417,657 | -1% | -$57,999 | ||||||
2024-03-15 | ALHC | Alignment Healthcare, Inc. | Maroney Dawn Christine | Pres, Markets | S - Sale | $4.89 | -21,537 | 2,015,361 | -1% | -$105,340 | ||||||
DM | 2024-03-05 | AMPX | Amprius Technologies, Inc. | Bornstein Jonathan | Pres of Amprius Lab | S - Sale+OE | $2.88 | -150,000 | 0 | -100% | -$432,041 | |||||
2024-02-23 | AMWL | American Well Corp | Paunovich Vukasin | EVP, Enterprise Platforms | S - Sale | $1.09 | -251,323 | 2,535,635 | -9% | -$274,369 | ||||||
2024-02-23 | AMWL | American Well Corp | Knight Kurt | COO | S - Sale | $1.09 | -283,079 | 3,114,004 | -8% | -$309,037 | ||||||
2024-02-23 | AMWL | American Well Corp | Gotlib Phyllis | Pres, International | S - Sale | $1.09 | -285,752 | 3,773,809 | -7% | -$311,955 | ||||||
2024-02-23 | AMWL | American Well Corp | Shepardson Robert | CFO | S - Sale | $1.09 | -319,214 | 2,845,148 | -10% | -$348,486 | ||||||
2024-02-23 | AMWL | American Well Corp | Weiler Kathy Johnson | Chief Comm., Growth Officer | S - Sale | $1.09 | -283,192 | 3,975,617 | -7% | -$309,161 | ||||||
2024-03-01 | AMWL | American Well Corp | Knight Kurt | COO | S - Sale | $1.07 | -38,747 | 3,075,257 | -1% | -$41,514 | ||||||
2024-03-01 | AMWL | American Well Corp | Gotlib Phyllis | Pres, International | S - Sale | $1.07 | -36,110 | 3,737,699 | -1% | -$38,688 | ||||||
2024-03-01 | AMWL | American Well Corp | Shepardson Robert | CFO | S - Sale | $1.07 | -68,303 | 2,776,845 | -2% | -$73,180 | ||||||
2024-03-01 | AMWL | American Well Corp | Paunovich Vukasin | EVP, Enterprise Platforms | S - Sale | $1.07 | -31,712 | 2,517,546 | -1% | -$33,976 | ||||||
2024-03-06 | ANGI | Angi Inc. | Shanmugasundaram Kulesh | CTO | S - Sale | $2.58 | -11,748 | 160,060 | -7% | -$30,310 | ||||||
2024-03-08 | APHP | American Picture House Corp | Macgregor Bannor Michael | CEO, 10% | S - Sale | $0.15 | -500,000 | 27,629,358 | -2% | -$75,000 | ||||||
2024-02-20 | APLD | Applied Digital Corp. | Moore Virginia | Dir | S - Sale | $4.74 | -30,000 | 224,821 | -12% | -$142,200 | ||||||
2024-03-01 | ARAY | Accuray Inc | Hoge Michael | SVP Global Operations | S - Sale | $2.59 | -11,991 | 390,208 | -3% | -$31,057 | ||||||
2024-03-14 | ASRT | Assertio Holdings, Inc. | Tyree James L | Dir | S - Sale | $1.12 | -10,251 | 188,251 | -5% | -$11,463 | ||||||
2024-03-04 | ATRA | Atara Biotherapeutics, Inc. | Touchon Pascal | Pres, CEO | S - Sale | $0.72 | -24,844 | 1,910,652 | -1% | -$17,888 | ||||||
M | 2024-02-20 | AUR | Aurora Innovation, Inc. | Hoffman Reid | Dir | S - Sale | $2.86 | -533,467 | 9,448,153 | -5% | -$1,523,429 | |||||
M | 2024-02-27 | AUR | Aurora Innovation, Inc. | Hoffman Reid | Dir | S - Sale | $2.56 | -3,292,249 | 9,283,540 | -26% | -$8,440,966 | |||||
M | 2024-02-29 | AUR | Aurora Innovation, Inc. | Hoffman Reid | Dir | S - Sale | $2.53 | -1,080,000 | 9,229,540 | -10% | -$2,728,940 | |||||
M | 2024-03-11 | BBAI | Bigbear.Ai Holdings, Inc. | Katz Avi S | Dir | S - Sale | $2.48 | -250,000 | 523,375 | -32% | -$619,911 | |||||
M | 2024-03-13 | BBAI | Bigbear.Ai Holdings, Inc. | Bbai Ultimate Holdings, LLC | Dir, 10% | S - Sale | $2.54 | -12,786,459 | 144,428,232 | -8% | -$32,509,930 | |||||
M | 2024-03-11 | BBAI | Bigbear.Ai Holdings, Inc. | Dinu Raluca | Dir | S - Sale | $2.48 | -250,000 | 523,374 | -32% | -$619,911 | |||||
2024-03-15 | BBAI | Bigbear.Ai Holdings, Inc. | Hayes Dorothy D | Dir | S - Sale | $2.43 | -12,000 | 209,401 | -5% | -$29,194 | ||||||
2024-03-11 | BBAI | Bigbear.Ai Holdings, Inc. | Ricker Sean Raymond | Chief Accounting Officer | S - Sale | $2.44 | -101,751 | 161,830 | -39% | -$248,272 | ||||||
M | 2024-03-08 | BBAI | Bigbear.Ai Holdings, Inc. | Bbai Ultimate Holdings, LLC | Dir, 10% | S - Sale | $2.63 | -7,529,548 | 157,214,691 | -5% | -$19,799,105 | |||||
M | 2024-02-29 | BFI | Burgerfi International, Inc. | John Rosatti Revocable Trust | 10% | S - Sale | $0.61 | -60,000 | 2,850,096 | -2% | -$36,874 | |||||
M | 2024-03-14 | BFI | Burgerfi International, Inc. | John Rosatti Revocable Trust | 10% | S - Sale | $0.61 | -60,000 | 2,768,396 | -2% | -$36,362 | |||||
2024-02-21 | BFI | Burgerfi International, Inc. | John Rosatti Revocable Trust | 10% | S - Sale | $0.69 | -20,000 | 3,010,096 | -1% | -$13,876 | ||||||
2024-03-05 | BFI | Burgerfi International, Inc. | John Rosatti Revocable Trust | 10% | S - Sale | $0.61 | -21,700 | 2,828,396 | -1% | -$13,220 | ||||||
M | 2024-02-22 | BFI | Burgerfi International, Inc. | John Rosatti Revocable Trust | 10% | S - Sale | $0.62 | -60,000 | 2,950,096 | -2% | -$37,468 | |||||
M | 2024-02-27 | BFI | Burgerfi International, Inc. | John Rosatti Revocable Trust | 10% | S - Sale | $0.60 | -40,000 | 2,910,096 | -1% | -$23,948 | |||||
2024-03-05 | BFLY | Butterfly Network, Inc. | Stoica Andrei G | CTO | S - Sale | $1.15 | -12,113 | 966,173 | -1% | -$13,930 | ||||||
2024-03-11 | BFLY | Butterfly Network, Inc. | Getz Heather C | EVP, CFO, COO | S - Sale | $1.14 | -81,448 | 1,435,788 | -5% | -$92,851 | ||||||
2024-03-11 | BFLY | Butterfly Network, Inc. | Stoica Andrei G | CTO | S - Sale | $1.14 | -76,498 | 889,675 | -8% | -$87,208 | ||||||
2024-02-28 | BIMI | Bimi Holdings Inc. | Tiewei Song | CEO | S - Sale | $4.08 | -4,000 | 337,117 | -1% | -$16,300 | ||||||
2024-03-01 | BIRD | Allbirds, Inc. | Vernachio Joseph | COO | S - Sale | $0.91 | -23,935 | 321,740 | -7% | -$21,661 | ||||||
D | 2024-02-23 | BKKT | Bakkt Holdings, Inc. | D'Annunzio Marc | GC, Secretary | S - Sale+OE | $0.88 | -50,247 | 566,630 | -8% | -$44,047 | |||||
2024-03-13 | BLDE | Blade Air Mobility, Inc. | Cohen Amir | Chief Accounting Officer | S - Sale | $2.70 | -8,057 | 99,602 | -7% | -$21,718 | ||||||
DM | 2024-03-13 | BLDE | Blade Air Mobility, Inc. | Tomkiel Melissa M. | Pres, GC | S - Sale+OE | $2.70 | -51,825 | 1,286,100 | -4% | -$139,694 | |||||
M | 2024-03-13 | BLDE | Blade Air Mobility, Inc. | Wiesenthal Robert S | CEO, 10% | S - Sale | $2.70 | -135,319 | 7,174,911 | -2% | -$364,753 | |||||
DM | 2024-03-13 | BLDE | Blade Air Mobility, Inc. | Heyburn William A. | CFO | S - Sale+OE | $2.70 | -53,842 | 1,380,020 | -4% | -$145,131 | |||||
2024-02-23 | BLND | Blend Labs, Inc. | Ghamsari Nima | Head of Blend | S - Sale | $2.23 | -112,108 | 116,474 | -49% | -$250,247 | ||||||
D | 2024-03-01 | BLUE | Bluebird Bio, Inc. | Colvin Richard A | Chief Medical Officer | S - Sale+OE | $1.53 | -6,770 | 118,368 | -5% | -$10,342 | |||||
M | 2024-02-20 | BRLT | Brilliant Earth Group, Inc. | Kuo Jeffrey Chuenhong | CFO | S - Sale | $2.85 | -23,510 | 298,274 | -7% | -$67,093 | |||||
M | 2024-03-07 | BTCS | Btcs Inc. | Handerhan Michal | COO, 10% | S - Sale | $1.52 | -97,618 | 1,613,878 | -6% | -$148,327 | |||||
2024-02-20 | BTCS | Btcs Inc. | Allen Charles W | CEO, 10% | S - Sale | $1.56 | -50,000 | 4,264,220 | -1% | -$78,020 | ||||||
M | 2024-03-05 | BTCS | Btcs Inc. | Handerhan Michal | COO, 10% | S - Sale | $1.55 | -52,382 | 1,711,496 | -3% | -$81,253 | |||||
2024-03-11 | CDTX | Cidara Therapeutics, Inc. | Tari Leslie | CHIEF SCIENTIFIC OFFICER | S - Sale | $0.67 | -21,029 | 260,165 | -7% | -$14,085 | ||||||
2024-03-11 | CDTX | Cidara Therapeutics, Inc. | Shah Preetam | CFO, CBO | S - Sale | $0.67 | -18,931 | 227,210 | -8% | -$12,680 | ||||||
2024-03-11 | CDTX | Cidara Therapeutics, Inc. | Ward Shane | COO, CLO | S - Sale | $0.67 | -20,473 | 198,770 | -9% | -$13,713 | ||||||
2024-03-11 | CDTX | Cidara Therapeutics, Inc. | Sandison Taylor | Chief Medical Officer | S - Sale | $0.67 | -20,662 | 347,095 | -6% | -$13,839 | ||||||
D | 2024-03-13 | CERS | Cerus Corp | Moore Carol | SVP Reg., Quality | S - Sale+OE | $2.02 | -20,619 | 490,623 | -4% | -$41,553 | |||||
DM | 2024-03-13 | CERS | Cerus Corp | Corash Laurence M | Chief Scientific Officer | S - Sale+OE | $2.02 | -28,427 | 2,339,740 | -1% | -$57,288 | |||||
DM | 2024-03-13 | CERS | Cerus Corp | Green Kevin Dennis | CFO | S - Sale+OE | $1.99 | -42,555 | 618,750 | -6% | -$84,882 | |||||
DM | 2024-03-13 | CERS | Cerus Corp | Benjamin Richard J | Chief Medical Officer | S - Sale+OE | $2.02 | -35,115 | 459,612 | -7% | -$70,766 | |||||
DM | 2024-03-13 | CERS | Cerus Corp | Jensen Chrystal | GC | S - Sale+OE | $2.02 | -35,284 | 490,912 | -7% | -$71,107 | |||||
DM | 2024-03-13 | CERS | Cerus Corp | Jayaraman Vivek K | COO | S - Sale+OE | $2.02 | -53,041 | 878,653 | -6% | -$106,892 | |||||
DM | 2024-03-13 | CERS | Cerus Corp | Greenman William Mariner | Pres, CEO | S - Sale+OE | $2.04 | -125,926 | 3,181,281 | -4% | -$256,377 | |||||
2024-03-08 | CERS | Cerus Corp | Benjamin Richard J | Chief Medical Officer | S - Sale | $2.40 | -29,378 | 478,061 | -6% | -$70,457 | ||||||
M | 2024-03-08 | CHPT | Chargepoint Holdings, Inc. | Linse Michael | Dir | S - Sale | $1.95 | -1,625,879 | 0 | -100% | -$3,176,541 | |||||
2024-02-28 | CKPT | Checkpoint Therapeutics, Inc. | Oliviero James F III | CEO, Pres, Dir | S - Sale | $2.06 | -5,894 | 341,780 | -2% | -$12,142 | ||||||
2024-02-21 | CRCT | Cricut, Inc. | Abdiel Capital Management, LLC | 10% | S - Sale | $4.83 | -1,000,000 | 10,584,341 | -9% | -$4,830,000 | ||||||
2024-03-07 | CRCT | Cricut, Inc. | Abdiel Capital Management, LLC | 10% | S - Sale | $4.45 | -5,273,978 | 190,616 | -97% | -$23,469,202 | ||||||
D | 2024-03-04 | DNA | Ginkgo Bioworks Holdings, Inc. | Dmytruk Mark E. | See Remarks | S - Sale+OE | $1.26 | -38,826 | 808,125 | -5% | -$48,765 | |||||
2024-03-06 | EVGO | Evgo Inc. | Kish Dennis G | Pres | S - Sale | $3.00 | -34,717 | 0 | -100% | -$104,151 | ||||||
2024-03-06 | EVGO | Evgo Inc. | Shevorenkova Olga | CFO | S - Sale | $3.00 | -19,363 | 81,991 | -19% | -$58,089 | ||||||
D | 2024-03-04 | EVLV | Evolv Technologies Holdings, Inc. | Chitkara Anil | Founder, Chief Growth Officer | S - Sale+OE | $3.63 | -34,065 | 1,200,157 | -3% | -$123,656 | |||||
D | 2024-03-04 | EVLV | Evolv Technologies Holdings, Inc. | George Peter Gustav | Pres, CEO | S - Sale+OE | $3.63 | -132,173 | 947,587 | -12% | -$479,788 | |||||
D | 2024-03-04 | EVLV | Evolv Technologies Holdings, Inc. | Donohue Mark | CFO | S - Sale+OE | $3.63 | -39,323 | 287,374 | -12% | -$142,742 | |||||
D | 2024-03-04 | EVLV | Evolv Technologies Holdings, Inc. | Ellenbogen Michael | Founder, Chief Innovation Ofc | S - Sale+OE | $3.63 | -38,356 | 4,379,422 | -1% | -$139,232 | |||||
2024-03-11 | EXFY | Expensify, Inc. | Vidal Daniel | Dir | S - Sale | $2.14 | -5,202 | 149,727 | -3% | -$11,132 | ||||||
2024-03-11 | EXFY | Expensify, Inc. | Mills Jason Fahr | Dir | S - Sale | $2.14 | -5,934 | 188,822 | -3% | -$12,699 |
A | Amended filing |
D | Derivative transaction in filing (usually option exercise) |
E | Error detected in filing |
M | Multiple transactions in filing; earliest reported transaction date and weighted average transaction price |
S - Sale | Sale of securities on an exchange or to another person |
S - Sale+OE | Sale of securities on an exchange or to another person (after option exercise) |
F - Tax | Payment of exercise price or tax liability using portion of securities received from the company |
P - Purchase | Purchase of securities on an exchange or from another person |